Clinical trial
A Randomized Trial to Investigate the Reset of Humoral Autoimmunity by Combining Belimumab With Rituximab in Severe Systemic Lupus Erythematosus
NCT03747159 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Trial to Investigate the Reset of Humoral Autoimmunity by Combining Belimumab With Rituximab in Severe Systemic Lupus Erythematosus
- Lead sponsor
- Leiden University Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 1, 2018
- Completion date
- June 22, 2026
- Enrollment
- 71 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.